Media Contact Health Ingredients Japan 2011: BASF unveils “Think Newtrition™” to the Japanese Market
BASF Japan Ltd. Corporate Communications
¾ New global initiative strengthens the company’s position as a Eriko Mugitani preferred solution partner for food, beverages and dietary Tel: 03-3796-4865 supplements
¾ Sustainability, Eco-efficiency, and Traceability (S.E.T.) program highlighted during the show Consumer Enlightenment Program continues to create demand for vitamin E
Tokyo, Japan – October 3, 2011 – BASF celebrates the Japanese
launch of the global “Think NewtritionTM” initiative in conjunction with
the legal integration of Cognis Japan into BASF Japan. Think NewtritionTM will be unveiled to the Japanese market at Health Ingredients exhibition from October 5 through 7 in Japan 2011, at
Tokyo Big Sight, following the legal integration of the two businesses
Think NewtritionTM is BASF’s new global market initiative to strengthen
the company’s position as a partner and driving force in the food, beverages and dietary supplements market segments, while aligning
nutrition products with the needs of today’s and tomorrow’s consumers.
“With Think NewtritionTM, we aim to start a dialog with the key players
in the market that will help us serve unmet consumer needs, and Corporate Communications
anticipate future issues. It represents a future-oriented approach for TEL: +813-3796-4863 customers that are striving to enhance their products and add health
http://www.japan.basf.com
appeal to their brands.” said Dr. Massimo Armada, Senior Vice
BASF has positioned itself as a market leader with consumer-focused
concepts and solutions, sustainability capabilities and tools for
customers, extensive operational, research and development expertise,
and services in applications and marketing. Customers can choose from a full range of ingredients, including nature-based, nature-identical
and synthetic varieties, to improve the health, taste and consumer
“With Think NewtritionTM we follow the underlying principle of ‘think
business-to-consumer and act business-to-business,” comments
Claudia Guterl, Vice President Global Marketing Human Nutrition BASF. “An example of this thinking is BASF’s Vitamin-E Consumer
Enlightenment Program: it raises consumer awareness of the health
benefits of vitamin E while at the same time offering relevant concepts
and solutions for our customers’ branded products, capitalizing on the
added value of the consumer enlightening project “E” icon” to
BASF is also serious about helping customers meeting the surging consumer demand for food safety and sustainability. As a result, the
Sustainability, Eco-efficiency, and Traceability (S.E.T.) program has been established and will be presented at Health Ingredients Japan. “BASF is a global leader in sustainable nutrition. With the tools included
in the S.E.T. program, customers can analyze and systematically
improve the sustainability of their products over time. On this basis, BASF Japan Ltd. customers can make verifiable value propositions to their customers Corporate Communications
and the consumer,” comments Ying Guo, Technical Marketing Human
Nutrition, who will be presenting on this topic on October 5, 4 p.m., on
About Nutrition & Health
BASF's Nutrition & Health division develops, produces and markets a comprehensive
range of products and services from the Pharmaceuticals, Aroma Chemicals, Human
Nutrition and Animal Nutrition industries. The division addresses customer needs and
enhances their consumers' well-being and quality of life. The division provides the
Pharmaceutical industry with active ingredients such as caffeine and ibuprofen, as
well as excipients and customized synthesis services. Nutrition & Health produces
Aroma Chemicals such as citral and geraniol for the Flavor and Fragrance industry.
Important Human Nutrition products are vitamins and carotenoids, plant sterols,
emulsifiers and omega-3 fatty acids. Its feed additives such as vitamins, carotenoids
and enzymesmake Nutrition & Health a worldwide leader for the Animal Nutrition
About BASF Japan
BASF started business in Japan in 1888. The BASF in Japan consists of eight
companies with BASF Japan Ltd at its core. Activities cover five business segments
that include chemicals, plastics, functional solutions, performance products and
Main production sites are in Yokkaichi (thermoplastic
polyurethanes [TPU] and polymer dispersions), Chigasaki (admixtures for concrete,
construction chemicals) and Totsuka (coatings). The Amagasaki R&D Center, located
close to many of the electronics technology leaders in Japan, focuses on innovative
solutions for LC display and energy management. In 2010, BASF in Japan accounted
for a total of 1,700 employees, and achieved sales of €1.7 billion. For further
information please visit: www.japan.basf.com
About BASF
BASF is the world’s leading chemical company: The Chemical Company. Its portfolio
ranges from chemicals, plastics, performance products and agricultural products to oil
and gas. As a reliable partner BASF creates chemistry to help its customers in
virtually all industries to be more successful. With its high-value products and
intelligent solutions, BASF plays an important role in finding answers to global
challenges such as climate protection, energy efficiency, nutrition and mobility. BASF
posted sales of about €63.9 billion in 2010 and had approximately 109,000 employees
as of the end of the year. BASF shares are traded on the stock exchanges in
Frankfurt (BAS), London (BFA) and Zurich (AN). Further information on BASF is
available on the Internet at www.basf.com or in its Social Media Newsroom at
- INFORMAÇÕES TÉCNICAS AOS PROFISSIONAIS DA SAÚDE Características Farmacológicas: Polizol é um anti-hemíntico polivalente, dotado de ação vermicida, ovicida e larvicida, exercendo sua atividade anti-helmíntica por bloqueio dos processos enzimáticos responsáveis pela absorção da glicose, com isto o nível de energia se torna inadequado à sobrevivência. Inicialmente os helmint
VI.- BIBLIOGRAFÍA Albus M, Hubmann W, Wahlheim C, Sobizack N, Franz V, Mohr F. Contrasts in neuropsychological test profile between patients with first-episode schizophrenia and first-episode affective disorders. Acta Psychiatry Scand 1996; 94:87-93. Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T. The course of geriatric depression with "reversible dementia": A controlled